Fig. 2: Study participant follow-up and malaria outcomes in the clinical trial.
DP indicates dihydroartemisinin-piperaquine.
Fig. 2: Study participant follow-up and malaria outcomes in the clinical trial. | Nature Communications
DP indicates dihydroartemisinin-piperaquine.
